OLD Category: methods

Re-Evaluating the Effects of Obesity on Cancer Immunotherapy Outcomes in Renal Cancer: What Do We Really Know?

• Farag KI, Makkouk A, Norian LA

A Novel miRNA–mRNA Axis Involves in Regulating Transcriptional Disorders in Pancreatic Adenocarcinoma

• Shang X, Shi LE, Taule D, Zhu ZZ

Immune and stromal scoring system associated with tumor microenvironment and prognosis: a gene-based multi-cancer analysis

• Zeng Z, Li J, Zhang J, Li Y, Liu X, Chen J, Huang Z, Wu Q, Gong Y, Xie C

Spatial omics and multiplexed imaging to explore cancer biology

• Lewis SM, Asselin-Labat ML, Nguyen Q, Berthelet J, Tan X, Wimmer VC, Merino D, Rogers KL, Naik SH

Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP

• Bernard S, Ghesquieres H, Casasnovas RO...Copie-Bergman C, Haioun C, Thieblemont C

The transcriptome of rabbit conjunctiva in dry eye disease: Large-scale changes and similarity to the human dry eye

• Master A, Kontzias A, Huang L, Huang W, Tsioulias A, Zarabi S, Wolek M, Wollocko BM, Honkanen R, Rigas B

Tissue Multiplex Analyte Detection in Anatomic Pathology – Pathways to Clinical Implementation

• Wharton KA, Wood D, Manesse M, Maclean KH, Leiss F, Zuraw A

The Pandora’s box of novel technologies that may revolutionize lung cancer

• Rad HS, Rad HS, Shiravand Y, Radfar P, Arpon D, Warkiani ME, O'Byrne K, Kulasinghe A

Upcoming treatments for morphea

• Wenzel D, Haddadi N, Afshari K, Richmond JM, Rashighi M

Single-cell and spatial analyses of cancer cells: toward elucidating the molecular mechanisms of clonal evolution and drug resistance acquisition

• Nagasawa S, Kashima Y, Suzuki A, Suzuki Y

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy

• Li R, He Y, Zhang H, Wang J, Liu X, Liu H, Wu H, Liang Z

Immune cell profiling in atherosclerosis: role in research and precision medicine

• Fernandez DM, Giannarelli C